On June 17, 2021 Multimeric Biotherapeutics, Inc., a biotechnology company developing vaccines against cancer and infectious diseases, reported that it has been accepted to present at the Keystone Symposium on Innovative Vaccine Approaches (Press release, Multimeric Biotherapeutics, JUN 17, 2021, View Source [SID1234585488]). The meeting will be held as a virtual web conference scheduled June 28-30, 2021.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!